Suzhou Porton Biologics Becomes First Chinese CDMO to Adopt MaxCyte’s ExPERT GTx Platform
Suzhou Porton Biologics Ltd, a biopharmaceutical company based in China, has announced the introduction of...
Suzhou Porton Biologics Ltd, a biopharmaceutical company based in China, has announced the introduction of...
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
China-based Contract Development and Manufacturing Organization (CDMO) Suzhou Porton Biologics Ltd has entered into a...
China-based Contract Development and Manufacturing Organization (CDMO) Suzhou Porton Biologics Ltd has entered into a...
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has entered into a...
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has announced a strategic...
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has struck a partnership...
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has partnered with Suzhou...
Suzhou Porton Biologics Ltd, a China-based contract development and manufacturing organization (CDMO), announced the completion...